FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808071963> ?p ?o ?g. }

• W2808071963 abstract "The preoperative neutrophil-to-lymphocyte ratio (NLR), C-reactive protein/albumin ratio (CRP/Alb ratio) and platelet-to-lymphocyte ratio (PLR) have been demonstrated to predict the clinical outcome of various human cancer, including renal cell carcinoma(RCC). The aim of our study was to explore the prognostic values of these ratios in patients with Xp11.2 translocation/TFE3 gene fusions renal cell carcinoma (Xp11.2 tRCC). A retrospective multicentre study was performed in 82 Xp11.2 tRCC patients who underwent radical or partial nephrectomy. The optimal cutoff values of the NLR, CRP/Alb ratio and PLR were determined by the receiver operating characteristic (ROC) analysis. The impact of the NLR, CRP/Alb ratio and PLR, as well as other clinicopathological characteristics, on disease-free survival (DFS) and overall survival (OS) were evaluated using the univariate and multivariate Cox regression analyses. The optimal cutoff values of the NLR, CRP/Alb ratio and PLR were set at 2.45, 140 and 0.08, respectively, according to the ROC analysis. Univariate analyses showed that the NLR, CRP/Alb ratio and PLR all were associated with DFS of Xp11.2 tRCC patients (P < 0.001, P = 0.005 and P = 0.001, respectively) and OS of Xp11.2 tRCC patients (P = 0.016, P = 0.003 and P = 0.014, respectively). Multivariate analysis indicated that the NLR was independently associated with DFS of Xp11.2 tRCC patients (hazard ratio [HR]: 4.25; 95% confidence interval [95% CI]: 1.19–15.18; P = 0.026) along with age (P = 0.004), the pT status (P < 0.001) and the pN status (P < 0.019), and the NLR (HR: 26.26; 95% CI: 1.44–480.3; P = 0.028) also was independently associated with OS in patients with Xp11.2 tRCC, along with age (P = 0.016) and a tumour thrombus (P = 0.007). Overall, relatively high NLRs, CRP/Alb ratios and PLRs were associated with a poor prognosis of Xp11.2 tRCC patients; among of them, only the NLR independently predicted the progression of Xp11.2 tRCC, and the NLR may help to identify patients with high metastasis or relapse risk." @default.
• W2808071963 created "2018-06-21" @default.
• W2808071963 creator A5004267224 @default.
• W2808071963 creator A5009706266 @default.
• W2808071963 creator A5020544737 @default.
• W2808071963 creator A5037740266 @default.
• W2808071963 creator A5059746697 @default.
• W2808071963 creator A5060264631 @default.
• W2808071963 creator A5060964356 @default.
• W2808071963 creator A5079674051 @default.
• W2808071963 date "2018-06-11" @default.
• W2808071963 modified "2023-10-15" @default.
• W2808071963 title "Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients" @default.
• W2808071963 cites W1537837390 @default.
• W2808071963 cites W1667507097 @default.
• W2808071963 cites W1894977339 @default.
• W2808071963 cites W190052799 @default.
• W2808071963 cites W1965037168 @default.
• W2808071963 cites W1971949115 @default.
• W2808071963 cites W1988511730 @default.
• W2808071963 cites W1993013170 @default.
• W2808071963 cites W1994072191 @default.
• W2808071963 cites W1995879127 @default.
• W2808071963 cites W2015143684 @default.
• W2808071963 cites W2016972161 @default.
• W2808071963 cites W2033658212 @default.
• W2808071963 cites W2042143188 @default.
• W2808071963 cites W2051455912 @default.
• W2808071963 cites W2051820020 @default.
• W2808071963 cites W2060709060 @default.
• W2808071963 cites W2064347516 @default.
• W2808071963 cites W2069804726 @default.
• W2808071963 cites W2086144867 @default.
• W2808071963 cites W2088001386 @default.
• W2808071963 cites W2110405319 @default.
• W2808071963 cites W2123105952 @default.
• W2808071963 cites W2139778116 @default.
• W2808071963 cites W2147712199 @default.
• W2808071963 cites W2168299243 @default.
• W2808071963 cites W2253806401 @default.
• W2808071963 cites W2265966046 @default.
• W2808071963 cites W2275876064 @default.
• W2808071963 cites W2426880766 @default.
• W2808071963 cites W2554323113 @default.
• W2808071963 cites W2559699418 @default.
• W2808071963 cites W2593924777 @default.
• W2808071963 cites W2609270575 @default.
• W2808071963 doi "https://doi.org/10.1186/s12894-018-0374-z" @default.
• W2808071963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5996532" @default.
• W2808071963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29890986" @default.
• W2808071963 hasPublicationYear "2018" @default.
• W2808071963 type Work @default.
• W2808071963 sameAs 2808071963 @default.
• W2808071963 citedByCount "11" @default.
• W2808071963 countsByYear W28080719632019 @default.
• W2808071963 countsByYear W28080719632020 @default.
• W2808071963 countsByYear W28080719632021 @default.
• W2808071963 countsByYear W28080719632022 @default.
• W2808071963 countsByYear W28080719632023 @default.
• W2808071963 crossrefType "journal-article" @default.
• W2808071963 hasAuthorship W2808071963A5004267224 @default.
• W2808071963 hasAuthorship W2808071963A5009706266 @default.
• W2808071963 hasAuthorship W2808071963A5020544737 @default.
• W2808071963 hasAuthorship W2808071963A5037740266 @default.
• W2808071963 hasAuthorship W2808071963A5059746697 @default.
• W2808071963 hasAuthorship W2808071963A5060264631 @default.
• W2808071963 hasAuthorship W2808071963A5060964356 @default.
• W2808071963 hasAuthorship W2808071963A5079674051 @default.
• W2808071963 hasBestOaLocation W28080719631 @default.
• W2808071963 hasConcept C126322002 @default.
• W2808071963 hasConcept C143998085 @default.
• W2808071963 hasConcept C144301174 @default.
• W2808071963 hasConcept C207103383 @default.
• W2808071963 hasConcept C2777472916 @default.
• W2808071963 hasConcept C2777761686 @default.
• W2808071963 hasConcept C2778963024 @default.
• W2808071963 hasConcept C2780091579 @default.
• W2808071963 hasConcept C2780227381 @default.
• W2808071963 hasConcept C38180746 @default.
• W2808071963 hasConcept C44249647 @default.
• W2808071963 hasConcept C50382708 @default.
• W2808071963 hasConcept C58471807 @default.
• W2808071963 hasConcept C71924100 @default.
• W2808071963 hasConcept C90924648 @default.
• W2808071963 hasConceptScore W2808071963C126322002 @default.
• W2808071963 hasConceptScore W2808071963C143998085 @default.
• W2808071963 hasConceptScore W2808071963C144301174 @default.
• W2808071963 hasConceptScore W2808071963C207103383 @default.
• W2808071963 hasConceptScore W2808071963C2777472916 @default.
• W2808071963 hasConceptScore W2808071963C2777761686 @default.
• W2808071963 hasConceptScore W2808071963C2778963024 @default.
• W2808071963 hasConceptScore W2808071963C2780091579 @default.
• W2808071963 hasConceptScore W2808071963C2780227381 @default.
• W2808071963 hasConceptScore W2808071963C38180746 @default.
• W2808071963 hasConceptScore W2808071963C44249647 @default.
• W2808071963 hasConceptScore W2808071963C50382708 @default.
• W2808071963 hasConceptScore W2808071963C58471807 @default.
• W2808071963 hasConceptScore W2808071963C71924100 @default.
• W2808071963 hasConceptScore W2808071963C90924648 @default.
• W2808071963 hasFunder F4320321001 @default.

• next